Cheng Cui
机构：Peking University, Peking University Third Hospital, Lee's Pharmaceutical (China) · ORCID：0000-0001-6446-0127
发表论文 66 篇 · 总被引 3299 次 · h-index 12
代表论文
- Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (2023 · Journal of Hepatocellular Carcinoma · 被引 11)
- Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies (2023 · Seminars in Arthritis and Rheumatism · 被引 11)
- Aging‐Related CYP3A Functional Changes in Chinese Older Patients: New Findings from Model‐Based Assessment of Amlodipine (2024 · Clinical Pharmacology & Therapeutics · 被引 10)
- A time series algorithm to predict surgery in neonatal necrotizing enterocolitis (2024 · BMC Medical Informatics and Decision Making · 被引 8)
- Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation (2024 · Clinical Pharmacokinetics · 被引 6)
- Odoribacter splanchnicus rescues aging-related intestinal P-glycoprotein damage via GDP-L-fucose secretion (2025 · Nature Communications · 被引 5)